In the early 2000s, the team of the IOI Oleo GmbH Pharma Business Unit asked themselves: Why do the principles and guidelines for active ingredients not also apply to excipients? As a result, the production site in Witten was GMP-certified, making IOI Oleo GmbH one of the first manufacturers of [...]

Medical applications and research have recently put cannabis in the spotlight and fueled a boom in demand. We now speak of a "green rush" - but what exactly triggered this demand? It is worth taking a closer look.

Hardly any other area today is as highly regulated by the legislature as the pharmaceutical industry. However, there are currently no manufacturing guidelines for lipid-based excipients, although most drugs consist for the largest part (75 to 99%) of excipients. The team of the Pharma Business Unit at IOI Oleo GmbH [...]

We got off to a running start in preparing for the CPhI Worldwide and intended to proudly present our new Corporate Design there, together with our completely revised catalogues. But, as everyone knows, all trade fairs were cancelled; we are therefore using this medium to bring you closer to our [...]

The health situation of companion and farm animals worldwide has developed and improved significantly in recent years. That is very largely due, on the one hand, to pharmaceutical products as well as biological and medically prescribed nutritional supplements and, on the other hand, to the raw materials used. And here [...]

The growing acceptance among customers and patients encourages market researchers to forecast outstanding growth potential for cannabidiol (CBD) and cannabis-based products. We have investigated intensively with this topic and wanted to find out which oil is best using acknowledged and objective methods.